Literature DB >> 10995248

Parasite-specific inhibition of the glycosylphosphatidylinositol biosynthetic pathway by stereoisomeric substrate analogues.

T K Smith1, M J Paterson, A Crossman, J S Brimacombe, M A Ferguson.   

Abstract

The natural substrate for the first alpha-D-mannosyltransferase of glycosylphosphatidylinositol biosynthesis in the protozoan parasite Trypanosoma brucei is D-GlcNalpha1-6-D-myo-inositol-1-P-sn-1, 2-diacylglycerol. Here we show that a diastereoisomer, D-GlcNalpha1-6-L-myo-inositol-1-P-sn-1,2-diacylglycerol, is an inhibitor of this enzyme in a trypanosomal cell-free system. Tests with other L-myo-inositol-containing compounds revealed that L-myo-inositol-1-phosphate is the principal inhibitory component and that methylation of the 2-OH group of the L-myo-inositol residue abolishes any inhibition. Comparisons between the natural substrate and the inhibitors suggested that the inhibitors bind to the first alpha-D-mannosyltransferase by means of charge interactions with the 1-phosphate group and/or hydrogen bonds involving the 3-, 4-, and 5-OH groups of the L-myo-inositol residue, which are predicted to occupy orientations identical to those of the 1-phosphate and 5-, 4-, and 3-OH groups, respectively, of the D-myo-inositol residue of the natural substrate. However, additional experiments indicated that the 4-OH group of the D-myo-inositol residue is unlikely to be involved in substrate recognition. None of the L-myo-inositol-containing compounds that inhibited glycosylphosphatidylinositol (GPI) biosynthesis in a parasite cell-free system had any effect on GPI biosynthesis in a comparable human (HeLa) cell-free system, suggesting that other related parasite-specific inhibitors of this essential pathway might be developed.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10995248     DOI: 10.1021/bi000854w

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  7 in total

1.  Specificity of GlcNAc-PI de-N-acetylase of GPI biosynthesis and synthesis of parasite-specific suicide substrate inhibitors.

Authors:  T K Smith; A Crossman; C N Borissow; M J Paterson; A Dix; J S Brimacombe; M A Ferguson
Journal:  EMBO J       Date:  2001-07-02       Impact factor: 11.598

2.  Chemical validation of GPI biosynthesis as a drug target against African sleeping sickness.

Authors:  Terry K Smith; Arthur Crossman; John S Brimacombe; Michael A J Ferguson
Journal:  EMBO J       Date:  2004-11-04       Impact factor: 11.598

Review 3.  Secretory pathway of trypanosomatid parasites.

Authors:  Malcolm J McConville; Kylie A Mullin; Steven C Ilgoutz; Rohan D Teasdale
Journal:  Microbiol Mol Biol Rev       Date:  2002-03       Impact factor: 11.056

4.  Inhibitors incorporating zinc-binding groups target the GlcNAc-PI de-N-acetylase in Trypanosoma brucei, the causative agent of African sleeping sickness.

Authors:  Nuha Z Abdelwahab; Arthur T Crossman; Lauren Sullivan; Michael A J Ferguson; Michael D Urbaniak
Journal:  Chem Biol Drug Des       Date:  2012-03       Impact factor: 2.817

5.  Discovery of inhibitors of Leishmania β-1,2-mannosyltransferases using a click-chemistry-derived guanosine monophosphate library.

Authors:  Phillip van der Peet; Julie E Ralton; Malcolm J McConville; Spencer J Williams
Journal:  PLoS One       Date:  2012-02-29       Impact factor: 3.240

6.  Fragment screening reveals salicylic hydroxamic acid as an inhibitor of Trypanosoma brucei GPI GlcNAc-PI de-N-acetylase.

Authors:  Michael D Urbaniak; Amy S Capes; Arthur Crossman; Sandra O'Neill; Stephen Thompson; Ian H Gilbert; Michael A J Ferguson
Journal:  Carbohydr Res       Date:  2013-12-30       Impact factor: 2.104

7.  Probing the substrate specificity of Trypanosoma brucei GlcNAc-PI de-N-acetylase with synthetic substrate analogues.

Authors:  Amy S Capes; Arthur Crossman; Michael D Urbaniak; Sophie H Gilbert; Michael A J Ferguson; Ian H Gilbert
Journal:  Org Biomol Chem       Date:  2014-02-12       Impact factor: 3.876

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.